Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $772.1300 (5.46%) ($772.1300 - $772.1300) on Thu. Aug. 3, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.86% (three month average) | RSI | 73 | Latest Price | $772.1300(5.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.8% a day on average for past five trading days. | Weekly Trend | REGN advances 1.7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(50%) XLV(50%) DIA(39%) XLF(38%) IVW(37%) | Factors Impacting REGN price | REGN will decline at least -0.93% in a week (0% probabilities). VXX(-37%) VIXM(-35%) GLD(-8%) USO(-6%) IGOV(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.93% (StdDev 1.86%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $746.27(3.47%) | 10 Day Moving Average | $740.23(4.31%) | 20 Day Moving Average | $728.66(5.97%) | To recent high | -3.9% | To recent low | 11.5% | Market Cap | $81.868b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |